Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at ASN Kidney Week 2026

Article summary

Fate Therapeutics shared updated preliminary clinical data for its FT819 cell therapy candidate during the American Society of Nephrology's Kidney Week 2026 conference.